Medical device recalls Moderate risk

GS Biomark LLC recalls CoViPoint COVID test kit (MultiPLEX/Direct) Kit Item Numbers: BC-DK0200; BM-AD4K0200 BM-ADK0200 BM-CDK0200 BM-CFDK0200…

Recall date
August 8, 2022
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
Z-0324-2023
FDA classification
Class II
Brand / firm
GS Biomark LLC
Sold / distributed
U.S.: TX, NY, GA, IN, MD, CA, PA, MD, DC, NJ, OR, WA O.U.S.: None

Why it was recalled

Distribution of COVID Test Kits without FDA Approval, Clearance or Authorization.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

CoViPoint COVID test kit (MultiPLEX/Direct) Kit Item Numbers: BC-DK0200; BM-AD4K0200 BM-ADK0200 BM-CDK0200 BM-CFDK0200 BM-D4K0200 BM-DK0200 BM-DK0600 BM-DK0800 BM-DK1200 BM-DK1400 BM-DK1800

Get recall alerts

Free email alert whenever GS Biomark LLC has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: GS Biomark LLC